| 1 |
How does the concept of “model as a dataset” reshape traditional data-sharing practices in medical imaging?
|
3. It enables sharing of learned model weights instead of sensitive raw images. |
|
จากบทความมีตอนที่กล่าวว่า model as a dataset มีความสามารถในการตอบคำถามได้คลอบคลุมจาก ข้อมูลดิบที่ละเอียด |
จากหัวข้อ Synthetic datasets กล่าวว่า "focusing on its strategic application in tackling complex scientific challenges rather than simply mimicking the statistical properties of the original data." |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which analytical conclusion can be drawn about the trade-offs between physics-informed and statistical models?
|
1. Statistical models require more domain-specific physics knowledge. |
|
จากหัวข้อ Synthetic datasets มีการกล่าวถึง physics-informed ว่าเป็นการใช้ rule-based หลักทฤษฎีในการตอบ แต่ statistical model ต้องการตัวอย่างที่มีคุณภาพสูง |
จากหัวข้อ Synthetic datasets ที่อธิบายความแตกต่างระหว่าง physics-informed และ statistical model |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is “mode collapse” considered a critical problem in GAN-based medical image synthesis?
|
5. It eliminates the need for validation datasets. |
|
จากหัวข้อ Synthetic datasets มีการกล่าวถึงว่า GANs based ไม่สามารถบันทึกการเปลี่ยนแปลงทั้งหมดได้ |
จากหัวข้อ Synthetic datasets มีการกล่าวถึงว่าGANs excel at generating high-quality samples but might not always capture all data variations, leading to low mode coverage, known as mode collapse. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Why are healthcare-specific metrics preferred over general-purpose metrics such as FID or SSIM?
|
2. They better capture clinical accuracy and diagnostic relevance. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the article identify as the key tension between privacy preservation and image fidelity?
|
1. Higher realism may risk reproducing identifiable patient data. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is the FDA’s approval of synthetic MRI technology significant for future AI-generated data?
|
1. It establishes a framework for validating synthetic data equivalence in clinical use. |
|
มีการกล่าวถึง FDA และ clinical validation |
จากหัวข้อ Future directions " FDA requiring extensive clinical validation to show that the diagnostic performance of the radiologist remained
equivalent when using synthetic images versus conven-
tional images. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which strategy would best mitigate demographic bias in generative models according to the article?
|
2. Applying diversity-aware training and fairness constraints |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How do DDPMs exemplify versatility in healthcare image synthesis?
|
2. They can perform multiple tasks such as denoising, inpainting, and anomaly detection without retraining. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What analytical insight does the article provide about integrating AI-generated medical images into education and research?
|
2. It enhances training by providing diverse, realistic datasets without ethical breaches. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Why is regional calibration essential when applying risk prediction models across countries?
|
2. To adjust for population-specific incidence and lifestyle differences |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What analytical conclusion can be drawn when comparing the China-PAR and Framingham models?
|
2. China-PAR uses local epidemiological data, leading to improved predictive validity. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Based on CVD mortality data, what analytical inference can be made about Japan’s position compared to neighboring countries?
|
1. Japan’s low CVD mortality suggests effective prevention and healthcare systems. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What analytical limitation arises when using Western-derived coefficients in East Asian models?
|
2. It introduces systematic overestimation of ASCVD probability. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What policy implication can be derived from country-specific risk models?
|
3. They are unnecessary for modern health systems. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
If a model excludes socioeconomic variables, what analytical consequence might occur?
|
5. Increased computational efficiency |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How might AI improve next-generation ASCVD risk prediction in East Asia?
|
2. By integrating multimodal data, including imaging and lifestyle information |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What conclusion can be drawn from comparing Mongolia’s and South Korea’s CVD mortality rates?
|
1. Mortality differences reflect varying effectiveness of national prevention programs. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the most logical future direction for improving ASCVD models across East Asia?
|
1. Establishing multinational data-sharing platforms to harmonize regional models |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
According to the “image generation trilemma” shown in the figure, what analytical conclusion can be drawn about the relative strengths of VAEs, GANs, and DDPMs in medical image synthesis?
|
2. GANs provide a balance between image quality and diversity but may suffer from mode collapse. |
|
จากบทความมีการกล่าวถึง GANs ว่าเป็นการ balance ระหว่าง good quality and diversity |
จาก figure 2 "GANs strike a balance, providing good quality and diversity but can suffer from mode collapse, thereby restricting the diversity." |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on Figure, what analytical conclusion can be drawn regarding the distribution of cardiovascular disease (CVD) subtypes across East Asian countries?
|
1. Ischemic heart disease (IHD) accounts for a higher proportion of CVD deaths in Japan and South Korea compared with China, suggesting regional lifestyle or prevention differences. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|